Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000246361 | SCV000313732 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV000871257 | SCV001012873 | likely benign | Multiple endocrine neoplasia, type 2 | 2024-01-14 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256185 | SCV002527932 | likely benign | Hereditary cancer-predisposing syndrome | 2021-02-03 | criteria provided, single submitter | curation | |
Fulgent Genetics, |
RCV002487137 | SCV002804163 | likely benign | Hirschsprung disease, susceptibility to, 1; Multiple endocrine neoplasia type 2B; Pheochromocytoma; Familial medullary thyroid carcinoma; Multiple endocrine neoplasia type 2A | 2022-04-22 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000871257 | SCV004818796 | likely benign | Multiple endocrine neoplasia, type 2 | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004791376 | SCV005403620 | benign | Multiple endocrine neoplasia type 2A | 2024-09-05 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |